David C Samuels1,2, Todd Hulgan3, Joshua P Fessel4,5,6, Frederic T Billings7, Jennifer L Thompson8, Rameela Chandrasekhar8, Timothy D Girard9. 1. Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, TN. 2. Department of Molecular Physiology & Biophysics, Vanderbilt University School of Medicine, Nashville, TN. 3. Division of Infectious Diseases in the Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN. 4. Division of Allergy, Pulmonary, and Critical Care Medicine in the Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN. 5. Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN. 6. Medical Service at the Department of Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN. 7. Division of Critical Care in the Department of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN. 8. Department of Biostatistics at the Vanderbilt University School of Medicine, Nashville, TN. 9. Clinical Research, Investigation, and Systems Modeling of Acute illness (CRISMA) Center in the Department of Critical Care Medicine, University of Pittsburgh School of Medicine.
Abstract
OBJECTIVES: Studies suggest that mitochondrial dysfunction underlies some forms of sepsis-induced organ failure. We sought to test the hypothesis that variations in mitochondrial DNA haplogroup affect susceptibility to sepsis-associated delirium, a common manifestation of acute brain dysfunction during sepsis. DESIGN: Retrospective cohort study. SETTING: Medical and surgical ICUs at a large tertiary care center. PATIENTS: Caucasian and African American adults with sepsis. MEASUREMENTS AND MAIN RESULTS: We determined each patient's mitochondrial DNA haplogroup using single-nucleotide polymorphisms genotyping data in a DNA databank and extracted outcomes from linked electronic medical records. We then used zero-inflated negative binomial regression to analyze age-adjusted associations between mitochondrial DNA haplogroups and duration of delirium, identified using the Confusion Assessment Method for the ICU. Eight-hundred ten patients accounted for 958 sepsis admissions, with 802 (84%) by Caucasians and 156 (16%) by African Americans. In total, 795 patient admissions (83%) involved one or more days of delirium. The 7% of Caucasians belonging to mitochondrial DNA haplogroup clade IWX experienced more delirium than the 49% in haplogroup H, the most common Caucasian haplogroup (age-adjusted rate ratio for delirium 1.36; 95% CI, 1.13-1.64; p = 0.001). Alternatively, among African Americans the 24% in haplogroup L2 experienced less delirium than those in haplogroup L3, the most common African haplogroup (adjusted rate ratio for delirium 0.60; 95% CI, 0.38-0.94; p = 0.03). CONCLUSIONS: Variations in mitochondrial DNA are associated with development of and protection from delirium in Caucasians and African Americans during sepsis. Future studies are now required to determine whether mitochondrial DNA and mitochondrial dysfunction contribute to the pathogenesis of delirium during sepsis so that targeted treatments can be developed.
OBJECTIVES: Studies suggest that mitochondrial dysfunction underlies some forms of sepsis-induced organ failure. We sought to test the hypothesis that variations in mitochondrial DNA haplogroup affect susceptibility to sepsis-associated delirium, a common manifestation of acute brain dysfunction during sepsis. DESIGN: Retrospective cohort study. SETTING: Medical and surgical ICUs at a large tertiary care center. PATIENTS: Caucasian and African American adults with sepsis. MEASUREMENTS AND MAIN RESULTS: We determined each patient's mitochondrial DNA haplogroup using single-nucleotide polymorphisms genotyping data in a DNA databank and extracted outcomes from linked electronic medical records. We then used zero-inflated negative binomial regression to analyze age-adjusted associations between mitochondrial DNA haplogroups and duration of delirium, identified using the Confusion Assessment Method for the ICU. Eight-hundred ten patients accounted for 958 sepsis admissions, with 802 (84%) by Caucasians and 156 (16%) by African Americans. In total, 795 patient admissions (83%) involved one or more days of delirium. The 7% of Caucasians belonging to mitochondrial DNA haplogroup clade IWX experienced more delirium than the 49% in haplogroup H, the most common Caucasian haplogroup (age-adjusted rate ratio for delirium 1.36; 95% CI, 1.13-1.64; p = 0.001). Alternatively, among African Americans the 24% in haplogroup L2 experienced less delirium than those in haplogroup L3, the most common African haplogroup (adjusted rate ratio for delirium 0.60; 95% CI, 0.38-0.94; p = 0.03). CONCLUSIONS: Variations in mitochondrial DNA are associated with development of and protection from delirium in Caucasians and African Americans during sepsis. Future studies are now required to determine whether mitochondrial DNA and mitochondrial dysfunction contribute to the pathogenesis of delirium during sepsis so that targeted treatments can be developed.
Authors: Antonio Federico; Elena Cardaioli; Paola Da Pozzo; Patrizia Formichi; Gian Nicola Gallus; Elena Radi Journal: J Neurol Sci Date: 2012-06-04 Impact factor: 3.181
Authors: Timothy D Girard; James C Jackson; Pratik P Pandharipande; Brenda T Pun; Jennifer L Thompson; Ayumi K Shintani; Sharon M Gordon; Angelo E Canonico; Robert S Dittus; Gordon R Bernard; E Wesley Ely Journal: Crit Care Med Date: 2010-07 Impact factor: 7.598
Authors: E W Ely; S K Inouye; G R Bernard; S Gordon; J Francis; L May; B Truman; T Speroff; S Gautam; R Margolin; R P Hart; R Dittus Journal: JAMA Date: 2001-12-05 Impact factor: 56.272
Authors: Angela Pyle; Thomas Foltynie; Watcharee Tiangyou; Claire Lambert; Sharon M Keers; Liesl M Allcock; Jill Davison; Simon J Lewis; Robert H Perry; Roger Barker; David J Burn; Patrick F Chinnery Journal: Ann Neurol Date: 2005-04 Impact factor: 10.422
Authors: Margaret A Pisani; Terrence E Murphy; Katy L B Araujo; Patricia Slattum; Peter H Van Ness; Sharon K Inouye Journal: Crit Care Med Date: 2009-01 Impact factor: 7.598
Authors: Pratik P Pandharipande; Brenda T Pun; Daniel L Herr; Mervyn Maze; Timothy D Girard; Russell R Miller; Ayumi K Shintani; Jennifer L Thompson; James C Jackson; Stephen A Deppen; Renee A Stiles; Robert S Dittus; Gordon R Bernard; E Wesley Ely Journal: JAMA Date: 2007-12-12 Impact factor: 56.272
Authors: Joana da Costa P d'Avila; Ana Paula S A Santiago; Rodrigo T Amâncio; Antonio Galina; Marcus F Oliveira; Fernando A Bozza Journal: Crit Care Med Date: 2008-06 Impact factor: 7.598
Authors: Alexander Semmler; Sven Hermann; Florian Mormann; Marc Weberpals; Stephan A Paxian; Thorsten Okulla; Michael Schäfers; Markus P Kummer; Thomas Klockgether; Michael T Heneka Journal: J Neuroinflammation Date: 2008-09-15 Impact factor: 8.322